Log in to save to my catalogue

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative coli...

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative coli...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e005dc0b914744f5a6450e4ff11d149a

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis

About this item

Full title

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2025-02, Vol.25 (1), p.50-21, Article 50

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Ulcerative colitis (UC) is a type of inflammatory bowel disease, and current treatments often fall short, necessitating new therapeutic options. Baicalin shows therapeutic promise in UC animal models, but a systematic review is needed.
A systematic search was conducted across databases including PubMed, EBSCO, Web of Science, and Science Direct,...

Alternative Titles

Full title

Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis–A preclinical systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e005dc0b914744f5a6450e4ff11d149a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e005dc0b914744f5a6450e4ff11d149a

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-025-03629-0

How to access this item